These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27273248)

  • 1. Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.
    Yamazaki T; Desai A; Han D; Kato K; Kowalski D; Akhtar S; Lademacher C; Kovanda L; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):93-101. PubMed ID: 27273248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects.
    Desai A; Yamazaki T; Dietz AJ; Kowalski D; Lademacher C; Pearlman H; Akhtar S; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):86-92. PubMed ID: 27278712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults.
    Townsend R; Dietz A; Hale C; Akhtar S; Kowalski D; Lademacher C; Lasseter K; Pearlman H; Rammelsberg D; Schmitt-Hoffmann A; Yamazaki T; Desai A
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):44-53. PubMed ID: 27273461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics.
    Townsend RW; Akhtar S; Alcorn H; Berg JK; Kowalski DL; Mujais S; Desai AV
    Eur J Clin Pharmacol; 2017 Jun; 73(6):669-678. PubMed ID: 28271239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects.
    Yamazaki T; Desai A; Goldwater R; Han D; Howieson C; Akhtar S; Kowalski D; Lademacher C; Pearlman H; Rammelsberg D; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):54-65. PubMed ID: 27273149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isavuconazole absorption following oral administration in healthy subjects is comparable to intravenous dosing, and is not affected by food, or drugs that alter stomach pH.
    Schmitt-Hoffmann A; Desai A; Kowalski D; Pearlman H; Yamazaki T; Townsend R
    Int J Clin Pharmacol Ther; 2016 Aug; 54(8):572-80. PubMed ID: 27345284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.
    Groll AH; Desai A; Han D; Howieson C; Kato K; Akhtar S; Kowalski D; Lademacher C; Lewis W; Pearlman H; Mandarino D; Yamazaki T; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):76-85. PubMed ID: 27273343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.
    Yamazaki T; Desai A; Goldwater R; Han D; Lasseter KC; Howieson C; Akhtar S; Kowalski D; Lademacher C; Rammelsberg D; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):66-75. PubMed ID: 27273004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557.
    Schmitt-Hoffmann A; Roos B; Spickermann J; Heep M; Peterfaí E; Edwards DJ; Stoeckel K
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4885-90. PubMed ID: 19667286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of
    Townsend R; Kato K; Hale C; Kowalski D; Lademacher C; Yamazaki T; Akhtar S; Desai A
    Clin Pharmacol Drug Dev; 2018 Feb; 7(2):207-216. PubMed ID: 28750160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients.
    Waters LJ; Moyle G; Bonora S; D'Avolio A; Else L; Mandalia S; Pozniak A; Nelson M; Gazzard B; Back D; Boffito M
    Antivir Ther; 2007; 12(5):825-30. PubMed ID: 17713166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral posaconazole on the pharmacokinetics of atazanavir alone and with ritonavir or with efavirenz in healthy adult volunteers.
    Krishna G; Moton A; Ma L; Martinho M; Seiberling M; McLeod J
    J Acquir Immune Defic Syndr; 2009 Aug; 51(4):437-44. PubMed ID: 19623694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.
    Klein CE; Chiu YL; Cai Y; Beck K; King KR; Causemaker SJ; Doan T; Esslinger HU; Podsadecki TJ; Hanna GJ
    J Clin Pharmacol; 2008 May; 48(5):553-62. PubMed ID: 18440920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment.
    Desai A; Schmitt-Hoffmann AH; Mujais S; Townsend R
    Antimicrob Agents Chemother; 2016 May; 60(5):3025-31. PubMed ID: 26953193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual pharmacokinetic interactions between bosentan and lopinavir/ritonavir in healthy participants.
    Dingemanse J; van Giersbergen PL; Patat A; Nilsson PN
    Antivir Ther; 2010; 15(2):157-63. PubMed ID: 20386070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects.
    Kaufmann P; Niglis S; Bruderer S; Segrestaa J; Äänismaa P; Halabi A; Dingemanse J
    Br J Clin Pharmacol; 2015 Oct; 80(4):670-7. PubMed ID: 25851691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
    Kovanda LL; Marty FM; Maertens J; Desai AV; Lademacher C; Engelhardt M; Lu Q; Hope WW
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Drug Interaction Between Isavuconazole and Tacrolimus: Is Empiric Dose Adjustment Necessary?
    Kufel WD; Armistead PM; Daniels LM; Ptachcinski JR; Alexander MD; Shaw JR
    J Pharm Pract; 2020 Apr; 33(2):226-230. PubMed ID: 30049245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of the lopinavir/ritonavir tablet 500/125 mg twice daily coadministered with efavirenz in healthy adult participants.
    Ng J; Chiu YL; Awni W; Bernstein B; Causemaker SJ; Klein CE
    J Clin Pharmacol; 2012 Aug; 52(8):1248-54. PubMed ID: 21719718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic Interactions Between Quinine and Lopinavir/Ritonavir in Healthy Thai Adults.
    Rattanapunya S; Cressey TR; Rueangweerayut R; Tawon Y; Kongjam P; Na-Bangchang K
    Am J Trop Med Hyg; 2015 Dec; 93(6):1383-90. PubMed ID: 26416104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.